PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 187 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $54,286,000 | +3.0% | 610,987 | +2.8% | 0.48% | +3.0% |
| Q4 2014 | $52,693,000 | -21.1% | 594,323 | -13.8% | 0.47% | -23.7% |
| Q3 2014 | $66,797,000 | +156.0% | 689,193 | +142.6% | 0.62% | +182.6% |
| Q2 2014 | $26,091,000 | +30.8% | 284,033 | -0.3% | 0.22% | +86.3% |
| Q1 2014 | $19,948,000 | +5.5% | 285,016 | -13.3% | 0.12% | +1.7% |
| Q4 2013 | $18,909,000 | -10.4% | 328,916 | -25.0% | 0.12% | -16.7% |
| Q3 2013 | $21,098,000 | +48.1% | 438,716 | -10.7% | 0.14% | +34.0% |
| Q2 2013 | $14,245,000 | – | 491,216 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |